SETD3 Methyltransferase Regulates PLK1 Expression to Promote In Situ Hepatic Carcinogenesis

SETD3 Methyltransferase Regulates PLK1 Expression to Promote In Situ Hepatic Carcinogenesis

BackgroundThe development of a new strategy to overcome chemoresistance to hepatocellular carcinoma (HCC) treatment is a long-standing issue. We have previously found that upregulated SETD3 levels are closely correlated with HCC. This study aims to explore the mechanism underlying how upregulation o...

Full description

Bibliographic Details
Main Authors: Meng Cheng, Qingmiao Yang, Yafei Liu, Meng-Jie Zhao, Xinyuan Du, Jiaqi Sun, Wen-Jie Shu, Zan Huang, Jianping Bi, Ximing Xu, Hai-Ning Du
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Oncology
Subjects:
hepatocellular carcinoma
SETD3
PLK1
gene expression
Sleep Beauty system
inhibitor
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.882202/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.882202/full

Similar Items